February 1, 2023
FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters
Editor's Note
The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious.
The recall was initiated because of a potential catheter hub defect that may cause leaks across the catheter’s tubes.
There have been reports of two injuries and no deaths related to this issue.
Distribution dates were March 19, 2022, to September 2, 2022.
Free Daily News
- Surgical robotics market accelerates as new players challenge industry giants
- Robotic surgery boosts 3-year relapse-free survival in rectal cancer
- Low-cost simulation helps surgical trainees practice crisis skills for major hemorrhage
- Nurse leaders weigh in on NCLEX pass rate decline, impact on workforce readiness
- FDA issues early alerts on multiple high-risk device recalls from J&J, Medtronic, Baxter, Boston Scientific
- New UCSF measure shows 1 in 60 cesarean deliveries involve serious surgical complications
- Hospitals can curb costly post-acute discharges with targeted periop programs, study finds
- Sameness in nursing care puts patients at risk
- CMS’s plan to phase out inpatient-only list could bolster rural ASCs
- AAAHC unveils v44 standards to sharpen focus on patient-centered ambulatory care
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement